The global biotechnology market is poised to expand at a CAGR of 12. 4% from 2016 to 2025. Some of the prominent players available in the market include Amgen Inc., Novartis AG, and Biogen Idec, Inc. The industry can be characterized by growing R&D activities and lower cost of DNA sequencing, which are key factors operating the overall growth of the industry. Furthermore, the dwindling source of natural resources and the growing demand for biological carbon fuel are expected to boost the industry’s revenue expansion.
North America is also expected to reign over the global biotechnology market through the forecast period. This region is normally dominated by the presence of major players in the field, and has great healthcare costs and R&D spending. Additionally , the developing awareness of biotechnology is maximizing the market’s growth in this region. Many companies in the area are introducing advanced items to meet the needs of the industry. In addition , the presence of main players in the region will support the market’s expansion.
Inflazome, an Irish biotechnology important link enterprise, is aiming to build up inflammasome blockers and is likely to be the primary player inside the Global Biotechnology Market simply by 2020. Additional key players in the market incorporate Johnson & Johnson, Celgene Corporation, Amgen, Inc., and Vertex Drugs, Inc. More compact companies such as Seagen Inc. are also poised to flourish in this market.